Stockscreener 앱 받기
215.73
3.79%
-8.5159
Cardinal Health Inc 주식(CAH)의 최신 뉴스
The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call - The Globe and Mail
The 5 Most Interesting Analyst Questions From Cardinal Health's Q4 Earnings Call - Finviz
Cardinal Health Inc (NYSE:CAH): A GARP Stock with Affordable Growth and Reasonable Valuation - ChartMill
Cardinal Health (NYSE:CAH) Given New $248.00 Price Target at Argus - MarketBeat
ING Groep NV Sells 77,635 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Wells Fargo Raises Price Target for Cardinal Health (CAH) | CAH Stock News - GuruFocus
Cardinal Health (NYSE:CAH) Given New $243.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Nasogastric Tubes Market Is Booming Worldwide 2026-2033 | - openPR.com
Wells Fargo Adjusts Price Target on Cardinal Health to $256 From $237, Maintains Overweight Rating - marketscreener.com
Candriam S.C.A. Acquires 19,155 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Fresh Look At Cardinal Health (CAH) Valuation After Mixed Recent Share Performance - Sahm
Earnings Winners: 2 Buy Rated Stocks Raising Guidance - Finviz
Lasix ONYU Gains Major Distributor Access Through Cardinal Health and Cencora - Pharmaceutical Commerce
Morgan Stanley raises Cardinal Health, Inc. (CAH) price target after strong Q2 - MSN
Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2 - Finviz
Cardinal Health CEO Jason Hollar says Central Ohio is key to achieving record revenueColumbus Business First - The Business Journals
Cardinal Health, Inc. (CAH) shares gain favor as Citi turns bullish on specialist assets - MSN
Cardinal Health, Inc. (NYSE:CAH) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - 富途牛牛
Why Cardinal Health (CAH) Is Up 5.3% After Raising Full-Year Earnings Guidance Again And Boosting Buybacks - Yahoo Finance
Cardinal Health price target raised to $255 from $245 at Morgan Stanley - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Cardinal Health (CAH) - The Globe and Mail
Cardinal Health (NYSE:CAH) Price Target Raised to $260.00 - MarketBeat
Cardinal Health, Inc. $CAH Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade) - Seeking Alpha
Cardinal Health Guidance Hike Sparks Questions On Valuation And Growth Drivers - Sahm
UBS Adjusts Cardinal Health Price Target to $260 From $250, Maintains Buy Rating - marketscreener.com
Cardinal Health (CAH) Receives Rating Update and Price Target In - GuruFocus
Cardinal Health stock hits all-time high at $229.87 By Investing.com - Investing.com Canada
Leerink Partners Raises Cardinal Health (NYSE:CAH) Price Target to $268.00 - MarketBeat
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock - Yahoo Finance
Evercore ISI Adjusts Cardinal Health Price Target to $260 From $250 - marketscreener.com
Mizuho Adjusts Price Target on Cardinal Health to $235 From $222, Maintains Outperform Rating - marketscreener.com
Cardinal Health, Inc. (NYSE:CAH) Q2 2026 Earnings Call Transcript - Insider Monkey
CAH Q4 Deep Dive: Specialty and Growth Segments Drive Outperformance and Upgraded Outlook - Finviz
Cardinal Health Q2 Earnings Call Highlights - MarketBeat
Is Cardinal Health (CAH) Pricing Reflect Its Surge And Role In The Healthcare Supply Chain - Yahoo Finance
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health (NYSE:CAH) Exceeds Q4 CY2025 Expectations - The Globe and Mail
Cardinal Health boosts annual profit forecast on surging demand for specialty drugs - 104.1 WIKY
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health boosts annual profit forecast banking on surging demand for specialty drugs - MSN
Cardinal Health Inc (CAH) Q2 2026 Earnings Call Highlights: Robu - GuruFocus
Cardinal Health Inc (CAH) Q2 2026 Earnings Call Highlights: Robust Revenue Growth and Raised ... By GuruFocus - Investing.com Canada
Why Is Cardinal Health (CAH) Stock Rocketing Higher Today - Finviz
Cardinal Health Shares Jump After Lifting Outlook on Pharma Momentum - The Wall Street Journal
Evercore ISI Raises Cardinal Health Price Target to $260 From $250 - marketscreener.com
Cardinal's Growth Engine Fires Across the Portfolio From Utilization Strength and New Acquisitions - morningstar.com
The $65.6 Billion Secret Wall Street Doesn’t Want You to Know About Cardinal Health - Yahoo Finance
Cardinal Health (CAH) Stock: Hits Fresh Momentum After Strong Q2 and $750M Buyback Boost - CoinCentral
Cardinal Health (NYSE:CAH) Releases Earnings Results - MarketBeat
Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. - Barron's
Cardinal Health Inc (CAH) Trading Down 0% on Feb 5 - GuruFocus
Cardinal Health Surges on Strong Q2 Results and Upgraded FY26 Ou - GuruFocus
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday - Benzinga
Cardinal Health CFO talks healthcare demand from aging population - Yahoo Finance
Cardinal Health (CAH) Sees Significant Stock Increase - GuruFocus
Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That. - Barron's
Cardinal Health (NYSE:CAH) Shares Gap Up Following Earnings Beat - MarketBeat
CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains - TradingView
Cardinal Health Smashes 52-Week High After Strong Quarter - Benzinga
Cardinal Health Q2 Earnings Report: What Investors Need to Know - Benzinga
Cardinal Health surges following quarterly earnings beats, guidance raise - Seeking Alpha
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next - TechStock²
Cardinal Health (CAH) Exceeds Revenue Expectations in Q2 - GuruFocus
4.36%
1.02%
자본화:
|
볼륨(24시간):